Costs per positive patient per day in the national data.

Human prevalence studies for Chikungunya virus in the Middle East and North Africa (n = 29).

Summary of reported outbreaks, case series, case reports, and cases in travelers for Chikungunya virus in the Middle East and North Africa.

Structural equation modeling for notified cases of Chikungunya virus (unadjusted model).

The European Food Safety Authority (EFSA), under request of the European Commission, performed an epidemiological analysis of the lumpy skin disease (LSD) epidemics based on the...

Top ranking locations based on profile of account for static and dynamic outbreak AI-related Tweets on October 26th, 2016.

The HIV status of 12 propofol injectors.

Results of negative binomial time series regression INARCH model for daily time series of AI-related Twitter activity (Log-likelihood: -920.29, AIC: 1854.58, log score: 60.59,...

Measles vaccine coverage before the outbreak in May 2011 and after the mass vaccination campaign in September 2013 and number of students vaccinated during the outbreak and...

Also shown are the R2 under the assumption that the temporal patterns in the data samples cause the temporal patterns in the news videos (I → V). The p-values testing for...

Blood meal exposure of Culex tarsalis females and resulting infection rates.

Structural equation modeling for confirmed cases of Chikungunya virus (unadjusted model).

Top ranking locations based on profile of account for static and dynamic outbreak AI-related Tweets.

Structural equation modeling for allochthonous/ imported cases of Chikungunya virus (unadjusted model).

Percentage morbidity and mortality are included where reported.

Stratified analysis for concomitant use of PPIs and quinolones (ciprofloxacin, moxifloxacin and levofloxacin).

Sex-specific hematological findings in CHIKV positive patients according to age groups.

Four measles outbreaks by region and vaccination status of case patients.

List of A. baumannii strains and genomes used for cgMLST A. baumannii target definition.

Seroprevalence (%) of rodent-borne pathogens by age (yrs).